$1.12
-0.03[-2.61%]
At close: May 7
$1.12
0[0.00%]
After Hours: 7:57PM EDT
Karyopharm Therapeutics
(NASDAQ:KPTI)Latest News for Karyopharm Therapeutics Stock (NASDAQ:KPTI)
Karyopharm Therapeutics Stock (NASDAQ: KPTI)
Categories: All
Wednesday, April 24, 2024
Wednesday, March 13, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
- Karyopharm Sees 2024 Total Revenue $140M-$160M vs $152.02M Est.Benzinga Newsdesk - Feb 29, 2024, 7:31AM
- Karyopharm Therapeutics Q4 2023 GAAP EPS $(0.36) Misses $(0.30) Estimate, Sales $33.75M Miss $35.40M EstimateBenzinga Newsdesk - Feb 29, 2024, 7:31AM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Tuesday, February 06, 2024
Monday, February 05, 2024
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Feb 5, 2024, 12:31PM
- Watching Karyopharm Therapeutics; Traders Circulate Analyst Comments Suggesting "With The MOR Takeover Interest, A Larger Cancer Company Could Also Be Interested In Acquiring KPTI For Selinexor"Benzinga Newsdesk - Feb 5, 2024, 12:23PM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Feb 5, 2024, 8:06AM
Wednesday, January 31, 2024
Monday, January 08, 2024
Friday, November 03, 2023
Thursday, November 02, 2023
- Karyopharm Maintains FY 2023 Revenue Guidance of $145M-$160M (Consensus Of $151.31M), Including U.S. XPOVIO Net Product Revenue Guidance of $110M-$125MBenzinga Newsdesk - Nov 2, 2023, 7:37AM
- Karyopharm Therapeutics Q3 EPS $(0.30) Misses $(0.28) Estimate, Sales $36.01M Miss $37.28M EstimateBenzinga Newsdesk - Nov 2, 2023, 7:36AM
- Earnings Scheduled For November 2, 2023Benzinga Insights - Nov 2, 2023, 4:56AM
Wednesday, November 01, 2023
Tuesday, September 26, 2023
Friday, September 08, 2023
Wednesday, September 06, 2023
Friday, September 01, 2023
Wednesday, August 30, 2023
Tuesday, August 29, 2023
Monday, August 07, 2023
Thursday, August 03, 2023
- 6 Analysts Have This to Say About Karyopharm TherapeuticsBenzinga Insights - Aug 3, 2023, 1:00PM
- Piper Sandler Maintains Overweight on Karyopharm Therapeutics, Lowers Price Target to $7Benzinga Newsdesk - Aug 3, 2023, 12:53PM
- RBC Capital Maintains Outperform on Karyopharm Therapeutics, Lowers Price Target to $4Benzinga Newsdesk - Aug 3, 2023, 10:12AM
- HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $10 Price TargetBenzinga Newsdesk - Aug 3, 2023, 6:10AM
Wednesday, August 02, 2023
- Earnings Scheduled For August 2, 2023Benzinga Insights - Aug 2, 2023, 8:45AM
- Karyopharm Therapeutics Sees FY23 Revenue $145M-$160M Vs $150.34M Est.Happy Mohamed - Aug 2, 2023, 7:33AM
- Karyopharm Therapeutics Q2 EPS $(0.29) Beats $(0.34) Estimate, Sales $37.58M Beat $36.23M EstimateHappy Mohamed - Aug 2, 2023, 7:32AM
Wednesday, July 26, 2023
- Karyopharm's Selinexor Shows Progression-Free Survival of 27.4 Months In Endometrial Cancer With Certain MutationVandana Singh - Jul 26, 2023, 9:33AM
- Wedbush Maintains Neutral on Karyopharm Therapeutics, Lowers Price Target to $4Benzinga Newsdesk - Jul 26, 2023, 8:39AM
- HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $10 Price TargetBenzinga Newsdesk - Jul 26, 2023, 6:12AM
- Late Tuesday, Karyopharm Announced Presentation Of Updated Exploratory Subgroup Analyses From SIENDO Study Of Selinexor For Advanced Or Recurrent TP53 Wild-type Endometrial Cancer At Virtual American Society Of Clinical Oncology Plenary SeriesBenzinga Newsdesk - Jul 26, 2023, 3:57AM
Tuesday, July 18, 2023
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Jul 18, 2023, 1:47PM
- Why Are Karyopharm Therapeutics Shares Gaining Today?Vandana Singh - Jul 18, 2023, 9:12AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Jul 18, 2023, 9:06AM
- Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving PremarketLisa Levin - Jul 18, 2023, 8:12AM
- 4 Analysts Have This to Say About Karyopharm TherapeuticsBenzinga Insights - Jul 18, 2023, 8:01AM
- Karyopharm shares are trading higher after the company received FDA Fast Track Designation for Selinexor for Myelofibrosis.Benzinga Newsdesk - Jul 18, 2023, 6:14AM
- HC Wainwright & Co. Reiterates Buy on Karyopharm Therapeutics, Maintains $10 Price TargetBenzinga Newsdesk - Jul 18, 2023, 6:10AM